MYH7 and neoplasm: To this end, 6 days after the injection of 5 × 106 J558 tumor cells, mice were randomized to treatment with a mIgG2a control antibody, anti-mPD-1 monotherapy, anti-mCD38 monotherapy, or the combination of both therapeutic antibodies (n = 10 mice/group; 3 independent experiments).